PREDISPOSITION TO AGE-RELATED YELLOW SPOT DEGENERATION
KNOWING YOUR PREDISPOSITION WILL ALLOW YOU TO START PREVENTING IMD IN ADVANCE
ARMS2 (G205T) and CFH (C1204T) genes, together account for about 70% of the risk of age-related macular degeneration
WHO DOES THE ANALYSIS SHOW?
In assessing the likelihood of disease progression in persons with early stages of age-related macular degeneration.
In determining the risk of developing TMD in persons with a family history of the disease.
In determining the risk of TMD in the presence of aggravating pathology (to take preventive measures).
In the differential diagnosis of ocular fundus pathology.
WHICH GENES ARE BEING TESTED?
The ARMS2 gene encodes a protein that is a component of the extracellular matrix of the chorioidea and is synthesized in the retina.
The CFH gene encodes Complement Factor H, which regulates the immune system's attack against infectious agents and pathologically altered cells.
WHAT'S THE RESULT?
As a result of the genetic study you get a conclusion about the degree of risk of developing age-related macular degeneration.
This test is a comprehensive genetic study that allows you to determine the risk of development and progression of age-related macular degeneration, which is characterized by a hereditary predisposition.
HOW TO TAKE THE TEST?
01
Take a blood sample from a vein or buccal epithelium (saliva) in a way that is convenient for you:
02
PAY in cash, online, by card or via bank
03
PICK UP THE RESULT in person/mail/texting in 7 working days
